Patients with NVAMD enjoy heretofore unprecedented vision gains when managed with anti-
VEGF therapy, and the limited body of evidence to date regarding long-term anti-VEGF …

Importance Understanding the importance of eye health to the US population across ethnic
and racial groups helps guide strategies to preserve vision in Americans and inform policy …

PURPOSE: To evaluate spectral-domain optical coherence tomography (SD OCT) roles for
imaging the retina of uncooperative subjects, infants, and pathologic features associated …

Purpose To determine whether scatter and grid laser photocoagulation (laser) adds benefit
to ranibizumab injections in patients with macular edema from retinal vein occlusion (RVO) …

Sickle cell disease (SCD), the most common inherited blood disorder, is characterized by
defective oxygen transport. Every part of the eye can be affected by microvascular …

Therapies targeting VEGF have proven only modestly effective for the treatment of
proliferative sickle cell retinopathy (PSR), the leading cause of blindness in patients with …

Purpose To determine the percentage of ranibizumab-treated patients with retinal vein
occlusion (RVO) who had resolution of edema for at least 6 months after the last injection …

Background While the development of targeted molecular therapy to inhibit vascular
endothelial growth factor (VEGF) has revolutionized the treatment and visual prognosis of …

Background Wide-field imaging is a newer retinal imaging technology, capturing up to 200
degrees of the retina in a single photograph. Individuals with sickle cell retinopathy …

Purpose To assess changes in retinal nonperfusion (RNP) in patients with retinal vein
occlusion (RVO) treated with ranibizumab. Design Secondary outcome measure in …